TickerFacts.

Minerva Neurosciences, Inc. (NERV): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$24.66M
Year ended 2022-12-31
$3.04M2013-12-31: -$2.16M2014-12-31: -$36.01M2017-12-31: $3.04M2022-12-31: -$24.66M-$24.66M
2013-12-31 Free Cash Flow (USD) 2022-12-31
Period endedFree Cash FlowChange YoYSource filing
2022-12-31-$24.66Mn/a2024-02-22, From 2022-01-01
No annual figure between 2017-12-31 and 2022-12-31.
2017-12-31$3.04Mn/a2019-03-12, From 2017-01-01
No annual figure between 2014-12-31 and 2017-12-31.
2014-12-31-$36.01Mn/m2017-03-13, From 2014-01-01
2013-12-31-$2.16Mn/a2015-03-26, From 2013-01-01